American College of Clinical Pharmacy
      Search      Cart
         

2025 ACCP/ASHP Pediatric Pharmacy Preparatory Review and Recertification Course


Format to Purchase:
Member Price:
$---.--
Nonmember Price:
$---.--

The ACCP/ASHP Pediatric Pharmacy Preparatory Review and Recertification Course is ideal for pharmacy professionals who are preparing for the Pediatric Pharmacy Specialty Certification Examination administered by the Board of Pharmacy Specialties (BPS) and for those seeking a self-paced review and refresher of disease states and therapeutics.

Developed by Board Certified Pharmacists and clinical experts, the course content is based on the domains, tasks and knowledge statements outlined in the BPS Pediatric Pharmacy content outline. The course content provides a comprehensive review of the knowledge domains covered in the specialty certification examination. The course uses case-based presentations for application to real-life scenarios, a practice exam along with correct answers, and links to the reference sources, and domains, tasks, and knowledge statements.

The course is available for continuing pharmacy education and recertification credit.

Release Date: September 17, 2025
BCPPS Deadline: September 15, 2026
ACPE Deadline: September 17, 2028

Technical Requirements:

Contents

Deep Vein Thrombosis and Metabolic Syndrome; Cardiovascular Disease; Neonatal Sepsis; Pediatric Nutrition - Module 1

Complex Case: Deep Vein Thrombosis and Metabolic Syndrome

Select Topics in Pediatric Cardiovascular Disease

Complex Case: Neonatal Sepsis

Select Topics in Pediatric Nutrition

Sickle Cell Disease with Vaso-Occlusive Crisis; Acute Lymphoblastic Leukemia with Tumor Lysis Syndrome; Pediatric Hematology and Oncology; Regulatory and IRB Considerations - Module 2

Complex Case: Sickle Cell Disease with Vaso-Occlusive Crisis

Complex Case: Acute Lymphoblastic Leukemia with Tumor Lysis Syndrome

Select Topics in Pediatric Hematology and Oncology

Regulatory and IRB Considerations

Acute Asthma; Pediatric Pulmonary Disease; Status Epilepticus and Cardiopulmonary Resuscitation; Pediatric Critical and Emergency Care - Module 3

Complex Case: Acute Asthma

Select Topics in Pediatric Pulmonary Disease

Complex Case: Status Epilepticus and Cardiopulmonary Resuscitation

Select Topics in Pediatric Critical and Emergency Care

Pediatric Neurology and Psychiatry; Pediatric Neurology - Focus on Seizures; Statistics, Evidence-Based Medicine and Research Design; Diabetic Ketoacidosis - Module 4

Select Topics in Pediatric Neurology and Psychiatry, Part 1

Select Topics in Pediatric Neurology - Part 2, Focus on Seizures

Statistics, Evidence-Based Medicine and Research Design

Complex Case: Diabetic Ketoacidosis

Pneumonia and Septic Shock; Pediatric Infectious Diseases - Part 1; Pediatric Infectious Diseases - Part 2; Medication Error & Practice Management - Module 5

Complex Case: Pneumonia and Septic Shock

Select Topics in Pediatric Infectious Diseases - Part 1

Select Topics in Pediatric Infectious Diseases - Part 2

Complex Case: Medication Error & Practice Management

Deep Vein Thrombosis and Metabolic Syndrome; Cardiovascular Disease; Neonatal Sepsis; Pediatric Nutrition - Module 1

*Content Matter Expert

Faculty

Emily A. Sheskey, Pharm.D., BCPPS

Clinical Pharmacist Specialist – Pediatric Ambulatory Care
University of Chicago Medicine
Comer Children’s Hospital
Chicago, Illinois

Amy Kiskaddon, Pharm.D., MBA, BCPPS, FCCM

Assistant Professor of Pediatrics
Johns Hopkins University School of Medicine
Baltimore, Maryland
Clinical Pharmacy Specialist – Heart Institute
Johns Hopkins All Children’s Hospital
St. Petersburg, Florida

Jamie L. Miller, Pharm.D., BCPPS, BCPS, FPPA, FASHP*

Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma

Dana Cerminara, Pharm.D., BCPPS

Clinical Pharmacy Specialist, Liver Transplant/GI/Hepatology/Nutrition
Texas Children’s Hospital
Houston, Texas

Sickle Cell Disease with Vaso-Occlusive Crisis; Acute Lymphoblastic Leukemia with Tumor Lysis Syndrome; Pediatric Hematology and Oncology; Regulatory and IRB Considerations - Module 2

Faculty

Ashley Sabus, Pharm.D., BCOP

Clinical Pharmacist Specialist
Children's Hospital Colorado
Clinical Assistant Professor
University of Colorado
Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado

Jennifer L. Thackray, Pharm.D., BCOP, BCPPS*

Manager, Pediatric Clinical Pharmacy Services and
Director, PGY2 Pediatric Oncology Residency Program
Memorial Sloan Ketting Cancer Center
New York, New York

Kate Gasparini, Pharm.D., BCOP, BCPPS

Pediatric Oncology Clinical Pharmacy Specialist III
Memorial Sloan Kettering Cancer Center
New York, New York

Peter N. Johnson, Pharm.D., BCPPS, FPPA, FCCM, FASHP*

Professor and President’s Associate Professor
University of Oklahoma College of Pharmacy
Pediatric Clinical Pharmacy Specialist—CICU
Oklahoma Children’s Hospital at OU Health
Oklahoma City, Oklahoma

Acute Asthma; Pediatric Pulmonary Disease; Status Epilepticus and Cardiopulmonary Resuscitation; Pediatric Critical and Emergency Care - Module 3

Faculty

Nicole E. Omecene, Pharm.D., BCPPS

Assistant Professor
Virginia Commonwealth University School of Pharmacy
Clinical Pharmacy Specialist
Children’s Hospital of Richmond at VCU
Richmond, Virginia

Jennifer Dannelley, Pharm.D.

Clinical Pharmacist
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma

Peter N. Johnson, Pharm.D., BCPPS, FPPA, FCCM, FASHP*

Professor and President’s Associate Professor
University of Oklahoma College of Pharmacy
Pediatric Clinical Pharmacy Specialist—CICU
Oklahoma Children’s Hospital at OU Health
Oklahoma City, Oklahoma

Long Nguyen, Pharm.D., BCPPS

Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York

Pediatric Neurology and Psychiatry; Pediatric Neurology - Focus on Seizures; Statistics, Evidence-Based Medicine and Research Design; Diabetic Ketoacidosis - Module 4

Faculty

Lauren Leiby, Pharm.D., BCPPS, FPPA, FCCM, FASHP

Behavioral Health Patient Care Pharmacist
Nationwide Children’s Hospital
Columbus, Ohio

Teia A. Brandenburg, Pharm.D., BCPPS

Clinical Pharmacist – Child Neurology
University of Kentucky HealthCare
Lexington, Kentucky

Emily Frederick, Pharm.D., BCPS

Associate Professor and Vice Chair
Sullivan University College of Pharmacy
Clinical Pharmacist
University of Louisville Hospital
Louisville, Kentucky

Rachel S. Meyers, Pharm.D., BCPS, BCPPS, FPPA

Clinical Professor
Ernest Mario School of Pharmacy
Rutgers University
Piscataway, New Jersey
Pediatric Clinical Pharmacist
Cooperman Barnabas Medical Center
Livingston, New Jersey

Pneumonia and Septic Shock; Pediatric Infectious Diseases - Part 1; Pediatric Infectious Diseases - Part 2; Medication Error & Practice Management - Module 5

Faculty

Kaitlin Hughes, Pharm.D., BCPPS

Clinical Pharmacist Specialist, Editorial Services
First Databank
Clinical Pharmacist PRN
Riley Hospital for Children
Indianapolis, Indiana

Katherine B. Olney, Pharm.D., BCIDP

Infectious Diseases Clinical Pharmacist
University of Kentucky Healthcare
Adjunct Assistant Professor
University of Kentucky College of Pharmacy
Lexington, Kentucky

Misty Oldham, Pharm.D., BCPS, AAHIVP

Associate Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma

Lisa T. Thames, Pharm.D., BCPS

Assistant Director, Inpatient Pharmacy Services
University of Florida Health Shands
Gainesville, Florida

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCPPS.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Target Audience: Pediatric Pharmacy Preparatory Review and Recertification Course is designed to help pharmacists who are preparing for the Board of Pharmacy Specialties certification examination in Pediatric Pharmacy as well as those seeking a general review and refresher on disease states and therapeutics.

Contents

Deep Vein Thrombosis and Metabolic Syndrome; Cardiovascular Disease; Neonatal Sepsis; Pediatric Nutrition - Module 1

Activity Number: 0204-9999-25-940-H01-P
Contact Hour(s): 5.00
Activity Type: Application Based
Learning Objectives

Complex Case: Deep Vein Thrombosis and Metabolic Syndrome

  • Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including deep vein thrombosis, type 2 diabetes mellitus, dyslipidemia, and hypertension.
  • Identify resources and treatment options for sexually transmitted infections.
  • Select appropriate monitoring considerations of anticoagulation medications.
  • Recognize the impact of pharmacogenomic differences on warfarin therapy.

Select Topics in Pediatric Cardiovascular Disease

  • Interpret signs, symptoms and diagnostic tests in a pediatric patient with congenital heart disease (specifically VSD, ASD, TOF, coarctation of aorta, and hypoplastic left heart) or Kawasaki disease.
  • Identify drug-related problems, including drug interactions.
  • Develop the most appropriate therapy and monitoring plans based on patient-specific information and the most current guidelines.
  • Use PALS to determine appropriate therapy for bradycardia and tachycardia.

Complex Case: Neonatal Sepsis

  • Develop appropriate treatment and monitoring plans for a complex neonatal patient with multiple conditions, including patent ductus arteriosus, apnea of prematurity, early and late onset sepsis, and necrotizing enterocolitis.
  • Evaluate the clinical and therapeutic implications of placental transfer of medications.
  • Identify age-specific pharmacokinetic differences among neonates, infants, children, and adolescents.
  • Apply FDA alerts for adverse drug events and drug-drug interactions into clinical practice.
  • Identify characteristics that facilitate transfer of medications into the breast milk.

Select Topics in Pediatric Nutrition

  • Evaluate if nutrition needs of a pediatric patient are being met based on assessment of appropriate growth and development.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with parenteral and enteral nutrition needs.
  • Evaluate patients for weight (overweight or obese) based on current guidelines.

Sickle Cell Disease with Vaso-Occlusive Crisis; Acute Lymphoblastic Leukemia with Tumor Lysis Syndrome; Pediatric Hematology and Oncology; Regulatory and IRB Considerations - Module 2

Activity Number: 0204-9999-25-941-H01-P
Contact Hour(s): 4.50
Activity Type: Application Based
Learning Objectives

Complex Case: Sickle Cell Disease with Vaso-Occlusive Crisis

  • Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including a vaso-occlusive crisis, cellulitis, constipation, and need for immunizations.
  • Select most appropriate patient controlled analgesia regimen based on vaso-occlusive crisis severity.
  • Apply pharmacodynamic principles when selecting appropriate antibiotic regimens.
  • Identify required immunizations for adolescents, including patients with risk factors for vaccine-preventable diseases.

Complex Case: Acute Lymphoblastic Leukemia with Tumor Lysis Syndrome

  • Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including acute lymphoblastic leukemia (ALL), tumor lysis syndrome, febrile neutropenia, invasive aspergillosis infection, and Clostridium difficile infection.
  • Select appropriate medication dose modifications related to hepatic impairment.

Select Topics in Pediatric Hematology and Oncology

  • Interpret signs, symptoms and diagnostic tests for chemotherapy-induced nausea and vomiting, mucositis, immune thrombocytopenia, infantile hemangioma, and palliative care in pediatric cancer patients.
  • Evaluate patient information to identify drug-related problems and response to therapy.
  • Identify appropriate modifications and supportive care plans based on patient-specific follow up assessment.

Regulatory and IRB Considerations

  • Identify appropriate off-label use of medications in the pediatric population.
  • Recognize IRB requirements for documentation of clinical studies.
  • List characteristics of patients who require informed assent/consent.
  • Recognize federal legislation relevant to the use of medications in pediatric patients.

Acute Asthma; Pediatric Pulmonary Disease; Status Epilepticus and Cardiopulmonary Resuscitation; Pediatric Critical and Emergency Care - Module 3

Activity Number: 0204-9999-25-942-H01-P
Contact Hour(s): 5.00
Activity Type: Application Based
Learning Objectives

Complex Case: Acute Asthma

  • Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including acute and chronic asthma, ADHD, acne, and GERD.
  • Evaluate essential components of social history, including smoke exposure and home environment.
  • Formulate a plan to address barriers to patient education and adherence, including age, language, cultural considerations, and inhaler technique.
  • Describe the impact of age on classification and management of asthma.
  • Assess available resources to improve access to medications, including patient assistance programs.

Select Topics in Pediatric Pulmonary Disease

  • For the following specific pulmonary topics: cystic fibrosis (exacerbation management) and chronic asthma management   
    • Interpret relevant clinical and laboratory data and results of diagnostic procedures in a pediatric patient with an exacerbation of cystic fibrosis or chronic asthma.
    • Identify relevant differences in laboratory sampling for pediatric patients (e.g., blood volume; method, frequency and timing of sampling).
    • Develop the most appropriate therapy and monitoring plans based on patient-specific information and the most current guidelines.

Complex Case: Status Epilepticus and Cardiopulmonary Resuscitation

  • Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions and needs, including status epilepticus, cardiopulmonary resuscitation, and sedation/analgesia.
  • Differentiate treatment options in cardiopulmonary arrest based upon patient presentation.
  • Select the appropriate dose and route of administration for medications.
  • Assess the need and processes for reporting adverse drug events.
  • Identify cultural considerations related to treatment and counseling of the pediatric population.
  • Distinguish between the four preceptor roles.

Select Topics in Pediatric Critical and Emergency Care

  • Interpret diagnostic and/or laboratory tests, vital signs, and clinical presentation of a pediatric patient with traumatic brain injury or select toxicological emergencies (e.g., acetaminophen, ethylene glycol).
  • Develop the most appropriate therapy and monitoring plans based on patient-specific information and the most current guidelines.
  • Develop appropriate medication dosing plans for a pediatric patient on ECMO.
  • Develop plans to manage underlying disorders.

Pediatric Neurology and Psychiatry; Pediatric Neurology - Focus on Seizures; Statistics, Evidence-Based Medicine and Research Design; Diabetic Ketoacidosis - Module 4

Activity Number: 0204-9999-25-943-H01-P
Contact Hour(s): 5.50
Activity Type: Application Based
Learning Objectives

Select Topics in Pediatric Neurology and Psychiatry, Part 1

  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with migraines, autism, cerebral palsy, depression or anxiety.
  • Evaluate patients for drug-related problems and response to therapy.
  • Identify appropriate modifications of patient-specific treatment plans based on follow up assessment.

Select Topics in Pediatric Neurology - Part 2, Focus on Seizures

  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with febrile seizures, neonatal seizures, infantile spasms, absence seizures, and Lennox-Gastaut syndrome.
  • Evaluate patients for drug-related problems.
  • Identify appropriate modifications of patient-specific treatment plans based on follow up assessment.

Statistics, Evidence-Based Medicine and Research Design

  • Evaluate quality and appropriateness, with specific attention to study design, statistical analysis, internal/external validity, source of bias/confounders, and quality of conclusions and interpretation of graphs.
  • Explain why a statistical test is appropriate or not appropriate, based on the sample distribution, data type, and study design.
  • Interpret clinical and statistical significance for results from commonly used statistical tests.
  • Explain the strengths and limitations of different types of measures of central tendency (mean, median, and mode) and data spread (standard deviation, standard error of the mean, range, and interquartile range).
  • Evaluate odds ratio, risk/incidence rate, relative risk, number needed to treat, number needed to harm, and other risk estimates.
  • Assess whether the study applies to a specified patient population.

Complex Case: Diabetic Ketoacidosis

  • Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including diabetic ketoacidosis, type 1 diabetes mellitus, and urinary tract infection.
  • Calculate maintenance and replacement fluid requirements and urine output.
  • Identify factors affecting medication adherence.
  • Recommend appropriate dosing of insulin based on patient age and weight.
  • Select an effective method of delivery for insulin.

Pneumonia and Septic Shock; Pediatric Infectious Diseases - Part 1; Pediatric Infectious Diseases - Part 2; Medication Error & Practice Management - Module 5

Activity Number: 0204-9999-25-944-H01-P
Contact Hour(s): 5.00
Activity Type: Application Based
Learning Objectives

Complex Case: Pneumonia and Septic Shock

  • Develop appropriate treatment and monitoring plans for a complex pediatric patient with multiple conditions, including pneumonia, septic shock, and acute kidney injury.
  • Calculate creatinine clearance, fluid requirements, and urine output in pediatric patients.
  • Apply scoring systems to assess pediatric patients.
  • Select appropriate dosing for medications based on renal dysfunction and/or replacement modalities.
  • Differentiate vital signs between stable and critically-ill pediatric patients.

Select Topics in Pediatric Infectious Diseases - Part 1

  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a well-appearing febrile infant.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with otitis media.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with bronchiolitis.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with tuberculosis.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with meningitis.
  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with pneumonia.

Select Topics in Pediatric Infectious Diseases - Part 2

  • Develop treatment and monitoring plans based on patient-specific information and the most current guidelines for a pediatric patient with HIV, Herpes Simplex Virus Types 1 and 2, or systemic fungal infections.

Complex Case: Medication Error & Practice Management

  • Incorporate position statements, white papers, national guidelines from recognized regulatory organizations into institutional policies and procedures related to: 

    • Medication reconciliation
    • Appropriate drug preparation and delivery (e.g., extemporaneous compounding and standardized concentrations) 
    • Selection of appropriate equipment/technology and decision support
    • Adverse drug event monitoring and reporting, or
    • Metrics for evaluating quality of pediatric pharmacy services.

Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.